BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28438129)

  • 1. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
    Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
    BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature.
    Trindade MA; Palermo ML; Pagliari C; Valente N; Naafs B; Massarollo PC; D'Albuquerque LA; Benard G
    Transpl Infect Dis; 2011 Feb; 13(1):63-9. PubMed ID: 20678090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of leprosy in central Florida.
    Anderson KL; Minni JP; Nowak MA; Karai LJ; Sanik E
    Cutis; 2017 Nov; 100(5):327-329. PubMed ID: 29232423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
    Front Immunol; 2018; 9():915. PubMed ID: 29867930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of leprosy.
    Kar HK; Gupta R
    Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.
    Geluk A; van Meijgaarden KE; Wilson L; Bobosha K; van der Ploeg-van Schip JJ; van den Eeden SJ; Quinten E; Dijkman K; Franken KL; Haisma EM; Haks MC; van Hees CL; Ottenhoff TH
    J Clin Immunol; 2014 Feb; 34(2):245-55. PubMed ID: 24370984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
    Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
    Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Painless Nodular Rash in a Young Man.
    Bass M; Foster K; Studdiford J
    Am Fam Physician; 2017 Aug; 96(3):189-190. PubMed ID: 28762689
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
    Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
    Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
    Chakraborty A; Ghosh R; Biswas A
    FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy.
    Singh I; Yadav AR; Mohanty KK; Katoch K; Bisht D; Sharma P; Sharma B; Gupta UD; Sengupta U
    Cell Immunol; 2012; 278(1-2):63-75. PubMed ID: 23121977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK
    Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
    [No Abstract]   [Full Text] [Related]  

  • 19. Lepromatous leprosy in a kidney transplant recipient: a case report.
    Ardalan M; Ghaffari A; Ghabili K; Shoja MM
    Exp Clin Transplant; 2011 Jun; 9(3):203-6. PubMed ID: 21649570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.